Table 2 Demographic characteristics of the patients

Age (years), mean ± SD

34.2 ± 10.3

Sex, M(%)/F (%)

6 (%50.0)/6 (%50.0)

Disease duration (years), mean ± SD

6.43 ± 6.90

Duration of amyloidosis (years), mean ± SD

3.9 ± 4.8

TCZ therapy duration (months), mean ± SD

17.5 ± 14.7

Number of applied TCZ doses, mean ± SD

15.3 ± 12.1

Co-existing diseases

n (%)

Ankylosing spondylitis

4 (%33.3)

Crohn’s disease

1 (%8.3)